ASX/CTE (ASX/CTE)

Australian Securities Exchange: ASX/CTE · AUD

A$1.22

+0.00 (0.0%)· Recorded snapshot

Market cap	59.5M
Revenue (ttm)	16.7M
Net income (ttm)	2.2M
EPS (ttm)	A$0.04
Shares out	48.8M
P/E (trailing)	28.1x
P/E (forward)	21.3x
Volume	31
Beta	0.15

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 16.7M
Net income (ttm): 2.2M
EPS (ttm): A$0.04
P/E (trailing): 28.1x
P/E (forward): 21.3x
Market cap: 59.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/E21.3

P25 14.6P50 21P75 31.9

Trailing P/E28.1

P25 15.4P50 29.4P75 64.4

ROE61.7

P25 -108P50 -50.6P75 1.1

ROIC21.7

P25 -64.5P50 -33.5P75 0.8

Benchmarks · 1M

All ASX/CTE indicators

Market & fundamental data

Available fields

237

Groups with data

Currency

AUD

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-26
Employees	27
Employees change	2
Employees growth	8%
Enterprise value	AUD 65M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	1999
Industry	Diagnostics & Research
Is primary listing	Yes
ISIN number	AU000000CTE1
Last earnings date	2026-02-20
Last refreshed	2026-10-30
Market cap	AUD 59.5M
Next earnings date	2026-11-26
Price	AUD 1.22
Price currency	AUD
Sector	Healthcare
SIC code	8090
Stock price date	2026-10-26
Symbol	asx/CTE
Website	https://www.cryosite.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	21.8x
Average P/E ratio (3Y)	22.65x
Average P/E ratio (5Y)	22.88x
Earnings yield	3.56%
EV/Earnings	29.09x
EV/EBIT	20.58x
EV/EBITDA	17.05x
EV/Sales	3.89x
FCF / EV yield	-12.38%
FCF yield	-13.51%
Forward P/E	21.27x
Graham number	0.31149
Graham upside	-74.47%
Industry forward P/E	17.45x
Industry P/E	63.53x
Lynch fair value	AUD 1.08
Lynch upside	-11.07%
P/B ratio	12.28x
P/E ratio	28.11x
P/OCF ratio	21.12x
P/S ratio	3.57x
Price / tangible book value	12.5x
Price/EBITDA ratio	16.76x
Sector forward P/E	34.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	18.92%
EBITDA margin	21.28%
Effective tax rate	29.14%
Gross margin	62.43%
Operating margin	18.92%
Pretax margin	18.89%
Profit margin	13.38%
Profit per employee	AUD 82,778
Profitable quarters	14
Profitable years	7
Revenue per employee	AUD 618,519
ROA	8.69%
ROA (5Y)	6.49%
ROCE	14.83%
ROE	61.75%
ROE (5Y)	85.89%
ROIC	21.69%
Tax / revenue	5.5%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	14.82%
EPS growth (Q)	2.36%
EPS growth (QoQ)	-6.17%
EPS growth 10Y	21.1%
EPS growth 3Y	14.56%
EPS growth 5Y	26.5%
EPS growth quarters	3
EPS growth years	5
Gross profit growth	17.27%
Gross profit growth (Q)	15.05%
Gross profit growth 3Y	13.27%
Gross profit growth 5Y	12.08%
Net income growth	18.63%
Net income growth (Q)	4.88%
Net income growth (QoQ)	-3.6%
Net income growth 3Y	16.62%
Net income growth 5Y	27.92%
Net income growth quarters	3
Net income growth years	5
OCF growth	36.63%
OCF growth (Q)	73.05%
OCF growth (QoQ)	30.96%
OCF growth 10Y	14.51%
OCF growth 3Y	26.05%
OCF growth 5Y	40.48%
Operating income growth	26.6%
Operating income growth (Q)	13.89%
Operating income growth 3Y	27.52%
Operating income growth 5Y	21.15%
Revenue growth	18.31%
Revenue growth (Q)	12.72%
Revenue growth (QoQ)	1.86%
Revenue growth 10Y	5.84%
Revenue growth 3Y	11.85%
Revenue growth 5Y	10.75%
Revenue growth quarters	4
Revenue growth years	9

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -10.9M
Depreciation and amortization	AUD 393,000
EBIT	AUD 3.2M
EBITDA	AUD 3.6M
EPS	AUD 0.04
FCF per share	AUD -0.16
Financing cash flow	AUD 5.1M
Free cash flow	AUD -8M
Gross profit	AUD 10.4M
Income taxes	AUD 919,000
Investing cash flow	AUD -10.7M
Net borrowing	AUD 5.3M
Net cash flow	AUD -2.8M
Net income	AUD 2.2M
Operating income	AUD 3.2M
Revenue	AUD 16.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.58
Book value per share	AUD 0.10
Debt / EBITDA	2.02
Debt / equity	1.59
Interest coverage	9.4
Long-term assets	AUD 19.8M
Long-term liabilities	AUD 16.5M
Net cash (debt)	AUD -5.5M
Net cash / market cap	-9.19%
Net debt / EBITDA	1.54
Net debt / equity	1.13
Piotroski F-Score	5
Property, plant and equipment	AUD 13.5M
Shareholders' equity	AUD 4.9M
Tangible book value	AUD 4.8M
Tangible book value per share	AUD 0.10
Total assets	AUD 26M
Total cash	AUD 2.2M
Total debt	AUD 7.7M
Total liabilities	AUD 21.1M
WACC	4.84%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.74
Current assets	AUD 6.2M
Current liabilities	AUD 4.7M
Current ratio	1.32
Inventory turnover	125.5
Net working capital	AUD -508,000
Quick ratio	1.03
Working capital	AUD 1.5M
Working capital turnover	5.71

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.35%
Dividend growth (10Y)	16.65%
Dividend growth (3Y)	91.29%
Dividend growth (5Y)	47.58%
Dividend per share	AUD 0.00
Last dividend	AUD 0.02
Shareholder yield	-3.35%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	525.64%
10Y return CAGR	22.23%
10Y total return	644.4%
150-day SMA	AUD 1.01
15Y price change	960.87%
15Y return CAGR	21.15%
15Y total return	1,677.93%
1D price change	0%
1M price change	3.39%
1M total return	3.39%
1W price change	-2.79%
1W total return	-2.79%
1Y price change	10.91%
1Y return CAGR	10.92%
1Y total return	10.91%
20-day SMA	AUD 1.21
200-day SMA	AUD 0.96
20Y price change	617.65%
20Y return CAGR	13.24%
20Y total return	1,102.72%
3M price change	1.67%
3M total return	1.67%
3Y price change	89.15%
3Y return CAGR	28.27%
3Y total return	111.08%
50-day SMA	AUD 1.15
50-day SMA vs 200-day SMA	50over200
52-week high	AUD 1.40
52-week high date	2026-08-25
52-week low	AUD 1.00
52-week low date	2026-05-21
5Y price change	258.82%
5Y return CAGR	32.94%
5Y total return	315.08%
6M price change	16.19%
6M total return	16.19%
All-time high	AUD 1.40
All-time high date	2026-08-25
All-time low	AUD 0.03
All-time low date	2019-04-30
Average true range (ATR)	AUD 0.04
Average volume	6K
Beta (1Y)	0.2
Beta (2Y)	0.1
Beta (5Y)	0.15
Change from 52-week high	-12.86%
Change from 52-week low	22%
Change from all-time high	-12.86%
Change from all-time low	3,712.5%
Change from open	0%
Dollar volume	AUD 37.82
High price	AUD 1.22
Low price	AUD 1.22
Monthly RSI	60.18
Open price	AUD 1.22
Price vs 150-day SMA	21.15%
Price vs 20-day SMA	0.49%
Price vs 200-day SMA	27.07%
Price vs 50-day SMA	5.9%
Relative volume	0.01
RSI	54.35
Sharpe ratio	0.86
Sharpe ratio (3Y)	0.91
Sharpe ratio (5Y)	0.73
Sortino ratio	1.37
Sortino ratio (3Y)	1.48
Sortino ratio (5Y)	1.26
Volume	31
Weekly RSI	61.2
YTD price change	22%
YTD total return	22%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11.1M
Shares change (QoQ)	2.62%
Shares change (YoY)	3.35%
Shares held by insiders	54.52%
Shares held by institutions	3.75%
Shares outstanding	48.8M

Deeper analysis on ASX/CTE

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/CTE report

Is a complete ASX/CTE research report available?

No complete published report is available for asx/CTE (ASX/CTE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/CTE (ASX/CTE)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/CTE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/CTE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/CTE

Frequently asked questions